Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Iovance Biotherapeutics Inc (IOVA)

Healthcare Biotechnology
4.10 $
-13.2% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Iovance Biotherapeutics Inc (IOVA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 86.9% of the shares are freely tradable; institutional investors hold 67.5%.

Ownership Structure

Institutional ownership
67.5%
Insiders
0.3%
Float
86.9%
Short % of float
24.8%
Shares Outstanding
447Mio.

Largest Shareholders

Institutions

Institutions IOVA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 6.96 31,080,505 +5.3 03/31/2026
Mhr Fund Management Llc 6.49 28,967,103 +0.0 03/31/2026
Vanguard Group Inc 6.09 27,207,079 +13.1 12/31/2025
State Street Corp 3.91 17,448,108 -13.5 03/31/2026
Vanguard Capital Management, LLC 3.72 16,617,737 +0.0 03/31/2026
Two Sigma Investments LLC 3.07 13,687,433 +211.2 03/31/2026
Vanguard Portfolio Management, LLC 2.62 11,700,844 +0.0 03/31/2026
Millennium Management LLC 2.11 9,414,292 +43.0 03/31/2026

Funds

Funds IOVA
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 2.79 12,478,346 +0.0 04/30/2026
State Street® SPDR® S&P® Biotech ETF 2.02 9,011,058 -0.6 05/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?